Biosimilar Newsletter Archive

  1. 11.07.19 -- Will Biosimilar Automatic Substitution Hit The EU5? 11/7/2019
    11/07/19 Biosimilar Development Newsletter
  2. 11.05.19 -- Top Considerations And Troubleshooting Tips For Protein Analysis 11/5/2019
    11/05/19 Biosimilar Development Newsletter
  3. 10.31.19 -- Global Biologics Access: What Is The U.S.' Role? 10/31/2019
    10/31/19 Biosimilar Development Newsletter
  4. 10.30.19 -- Droplet Digital PCR Breaks The Limits Of Nucleic Acid Detection And Quantification 10/30/2019
    10/30/19 Biosimilar Development Newsletter
  5. 10.27.19 -- Inside The Great Canadian Biosimilar Transition 10/27/2019
    10/27/19 Biosimilar Development Newsletter
  6. 10.24.19 -- Inside The Great Canadian Biosimilar Transition 10/24/2019
    10/24/19 Biosimilar Development Newsletter
  7. 10.22.19 -- Addressing The Challenges Of Next-Generation Biotherapeutics 10/22/2019
    10/22/19 Biosimilar Development Newsletter
  8. 10.17.19 -- Comparative Biosimilar Trials: More Questions Than Answers? 10/17/2019
    10/17/19 Biosimilar Development Newsletter
  9. 10.15.19 -- Scale-Up Strategies For Retroviruses, Mabs, And More 10/15/2019
    10/15/19 Biosimilar Development Newsletter
  10. 10.10.19 -- FDA's Woodcock: Biosimilar Development Promotes Better Biologics 10/10/2019
    10/10/19 Biosimilar Development Newsletter